<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font7" size="10" family="Symbol" color="#000000"/>
<text top="41" left="55" width="189" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Health and Quality of Life Outcomes 2007, 5 :25<i>Health and Quality of Life Outcomes</i></text>
<text top="41" left="414" width="140" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.hqlo.com/content/5/1/25</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="106" segment_no="11" tag_type="text">Page 2 of 7<b>5</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="107" segment_no="12" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="60" height="10" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Background</text>
<text top="98" left="55" width="241" height="9" font="font5" id="p1_t6" reading_order_no="3" segment_no="4" tag_type="text">Women diagnosed with gynecologic cancer are at risk for</text>
<text top="110" left="55" width="241" height="9" font="font5" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="text">depression, anxiety and reduced quality of life (QoL) [1-<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font5" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="text">4]. QoL is an important component of assessing the<b>Background</b></text>
<text top="134" left="55" width="241" height="9" font="font5" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">effects of surgery, radiation, and chemotherapy [5]. In</text>
<text top="145" left="55" width="241" height="9" font="font5" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="text">addition to clinical variables, QoL in cancer patients<a href="">1-</a></text>
<text top="157" left="55" width="241" height="9" font="font5" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="text">undergoing treatment is affected by demographic varia-<a href="">4]. QoL</a> is an important component of assessing the</text>
<text top="169" left="55" width="241" height="9" font="font5" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="text">bles, socio-economic status, social characteristics and per-<a href="">herapy [5]. In</a></text>
<text top="181" left="55" width="241" height="9" font="font5" id="p1_t13" reading_order_no="10" segment_no="4" tag_type="text">sonal expectations [6,7]. Pretreatment factors have been</text>
<text top="192" left="55" width="241" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">found to influence QoL in patients undergoing radiation</text>
<text top="204" left="55" width="241" height="9" font="font5" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">therapy [8]. Significant differences in QoL were found as</text>
<text top="216" left="55" width="241" height="9" font="font5" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">a function of age, race, Karnofsky Performance Status<a href=""> [6,7]. Pret</a>reatment factors have been</text>
<text top="228" left="55" width="241" height="9" font="font5" id="p1_t17" reading_order_no="14" segment_no="4" tag_type="text">(KPS), income level and employment status [8]. Pretreat-</text>
<text top="239" left="55" width="241" height="9" font="font5" id="p1_t18" reading_order_no="15" segment_no="4" tag_type="text">ment Functional Assessment of Cancer Therapy (FACT-G)<a href="">erapy [8]. Significan</a>t differences in QoL were found as</text>
<text top="251" left="55" width="241" height="9" font="font5" id="p1_t19" reading_order_no="16" segment_no="4" tag_type="text">scores were higher in patients who were older, white, had</text>
<text top="263" left="55" width="241" height="9" font="font5" id="p1_t20" reading_order_no="17" segment_no="4" tag_type="text">higher KPS scores, were married, had a higher income and<a href="">8</a>]. Pretreat-</text>
<text top="275" left="55" width="241" height="9" font="font5" id="p1_t21" reading_order_no="18" segment_no="4" tag_type="text">were college graduates. Gender and primary site of disease</text>
<text top="286" left="55" width="241" height="9" font="font5" id="p1_t22" reading_order_no="19" segment_no="4" tag_type="text">did not have an effect. Arredondo et al. examined QoL in</text>
<text top="298" left="55" width="241" height="9" font="font5" id="p1_t23" reading_order_no="20" segment_no="4" tag_type="text">men with prostate cancer and found men with more</text>
<text top="310" left="55" width="241" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="4" tag_type="text">comorbidities had significantly worse scores at baseline in</text>
<text top="322" left="55" width="107" height="9" font="font5" id="p1_t25" reading_order_no="22" segment_no="4" tag_type="text">the physical domains [9].</text>
<text top="345" left="55" width="241" height="9" font="font5" id="p1_t26" reading_order_no="23" segment_no="6" tag_type="text">Pretreatment characteristics may affect patients' reaction</text>
<text top="357" left="55" width="241" height="9" font="font5" id="p1_t27" reading_order_no="24" segment_no="6" tag_type="text">to their illness and treatment and thus influence disease</text>
<text top="369" left="55" width="241" height="9" font="font5" id="p1_t28" reading_order_no="25" segment_no="6" tag_type="text">specific QoL scores measured during treatment. The role<a href="">9</a>].</text>
<text top="380" left="55" width="241" height="9" font="font5" id="p1_t29" reading_order_no="26" segment_no="6" tag_type="text">these baseline characteristics play in women's ability to</text>
<text top="392" left="55" width="241" height="9" font="font5" id="p1_t30" reading_order_no="27" segment_no="6" tag_type="text">maintain good QoL following diagnosis and during treat-</text>
<text top="404" left="55" width="241" height="9" font="font5" id="p1_t31" reading_order_no="28" segment_no="6" tag_type="text">ment may therefore affect assessment of treatment and</text>
<text top="416" left="55" width="241" height="9" font="font5" id="p1_t32" reading_order_no="29" segment_no="6" tag_type="text">become a factor in determining which treatments are</text>
<text top="427" left="55" width="241" height="9" font="font5" id="p1_t33" reading_order_no="30" segment_no="6" tag_type="text">selected. A health status questionnaire was used to capture</text>
<text top="439" left="55" width="241" height="9" font="font5" id="p1_t34" reading_order_no="31" segment_no="6" tag_type="text">the effect of general physical and mental health as exten-</text>
<text top="451" left="55" width="241" height="9" font="font5" id="p1_t35" reading_order_no="32" segment_no="6" tag_type="text">sive personal information was not available on these</text>
<text top="463" left="55" width="241" height="9" font="font5" id="p1_t36" reading_order_no="33" segment_no="6" tag_type="text">women. The SF-36 was selected as it provides a measure of</text>
<text top="474" left="55" width="241" height="9" font="font5" id="p1_t37" reading_order_no="34" segment_no="6" tag_type="text">the health burden of chronic disease and other medical</text>
<text top="486" left="55" width="241" height="9" font="font5" id="p1_t38" reading_order_no="35" segment_no="6" tag_type="text">conditions that the women may have [10]. Baseline, pre-</text>
<text top="498" left="55" width="241" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="6" tag_type="text">operative, data from longitudinal studies of women with</text>
<text top="510" left="55" width="241" height="9" font="font5" id="p1_t40" reading_order_no="37" segment_no="6" tag_type="text">endometrial or ovarian cancer [11,12] were analyzed to</text>
<text top="521" left="55" width="241" height="9" font="font5" id="p1_t41" reading_order_no="38" segment_no="6" tag_type="text">determine the degree to which QoL, measured with a dis-<a href="">10]</a>. Baseline, pre-</text>
<text top="533" left="55" width="241" height="9" font="font5" id="p1_t42" reading_order_no="39" segment_no="6" tag_type="text">ease specific questionnaire, is affected by baseline differ-</text>
<text top="545" left="55" width="241" height="9" font="font5" id="p1_t43" reading_order_no="40" segment_no="6" tag_type="text">ences in demographic variables, and physical and mental<a href="">[11,12] wer</a>e analyzed to</text>
<text top="557" left="55" width="241" height="9" font="font5" id="p1_t44" reading_order_no="41" segment_no="6" tag_type="text">health measured with the SF-36. At the time these data</text>
<text top="568" left="55" width="241" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="6" tag_type="text">were obtained, women were unaware of their ultimate</text>
<text top="580" left="55" width="241" height="9" font="font5" id="p1_t46" reading_order_no="43" segment_no="6" tag_type="text">diagnosis and/or stage of disease. Women with an adnexal</text>
<text top="592" left="55" width="241" height="9" font="font5" id="p1_t47" reading_order_no="44" segment_no="6" tag_type="text">mass determined at surgery to be benign were included to</text>
<text top="604" left="55" width="129" height="9" font="font5" id="p1_t48" reading_order_no="45" segment_no="6" tag_type="text">control for the effect of cancer.</text>
<text top="627" left="55" width="43" height="10" font="font4" id="p1_t49" reading_order_no="46" segment_no="8" tag_type="title">Methods</text>
<text top="639" left="55" width="241" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="9" tag_type="text">This prospective study was conducted at two gynecologic</text>
<text top="651" left="55" width="241" height="9" font="font5" id="p1_t51" reading_order_no="48" segment_no="9" tag_type="text">oncology offices located in Northeastern Ohio. Consecu-</text>
<text top="662" left="55" width="241" height="9" font="font5" id="p1_t52" reading_order_no="49" segment_no="9" tag_type="text">tive patients requiring surgery for a pelvic mass or a posi-<b>Methods</b></text>
<text top="674" left="55" width="241" height="9" font="font5" id="p1_t53" reading_order_no="50" segment_no="9" tag_type="text">tive endometrial biopsy (endometrial cancer) were</text>
<text top="686" left="55" width="241" height="9" font="font5" id="p1_t54" reading_order_no="51" segment_no="9" tag_type="text">enrolled in a longitudinal assessment of QoL study at</text>
<text top="698" left="55" width="241" height="9" font="font5" id="p1_t55" reading_order_no="52" segment_no="9" tag_type="text">their pre-operative visit between January 2001 and July</text>
<text top="709" left="55" width="24" height="9" font="font5" id="p1_t56" reading_order_no="53" segment_no="9" tag_type="text">2004.</text>
<text top="87" left="313" width="241" height="9" font="font5" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">Questionnaires (described below) were completed at the</text>
<text top="98" left="313" width="241" height="9" font="font5" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">initial office visit following informed consent to partici-</text>
<text top="110" left="313" width="241" height="9" font="font5" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">pate in this IRB approved study. Baseline demographics</text>
<text top="122" left="313" width="241" height="9" font="font5" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">were ascertained by interview with a research assistant.</text>
<text top="134" left="313" width="241" height="9" font="font5" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">Private office records were reviewed to obtain height,</text>
<text top="145" left="313" width="241" height="9" font="font5" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">weight and diagnosis following surgery. Body mass index</text>
<text top="157" left="313" width="241" height="9" font="font5" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">(BMI) was calculated (defined as weight (kg) divided by</text>
<text top="168" left="313" width="241" height="10" font="font5" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">height (m 2 ) for each woman) and categorized as normal</text>
<text top="181" left="313" width="241" height="9" font="font5" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">weight (18.5–24.9), overweight (25–29.9) or obese (BMI</text>
<text top="190" left="313" width="241" height="13" font="font7" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">≥ 30) [13]. Smoking was quantified in pack years, a</text>
<text top="204" left="313" width="241" height="9" font="font5" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">method used to measure the amount a person has</text>
<text top="216" left="313" width="241" height="9" font="font5" id="p1_t68" reading_order_no="65" segment_no="3" tag_type="text">smoked over a long period of time. It is calculated by mul-</text>
<text top="228" left="313" width="241" height="9" font="font5" id="p1_t69" reading_order_no="66" segment_no="3" tag_type="text">tiplying the number of packs of cigarettes smoked per day</text>
<text top="239" left="313" width="219" height="9" font="font5" id="p1_t70" reading_order_no="67" segment_no="3" tag_type="text">by the number of years the person has smoked [14].</text>
<text top="263" left="313" width="241" height="9" font="font5" id="p1_t71" reading_order_no="68" segment_no="5" tag_type="text">General health status was measured with the Short Form</text>
<text top="275" left="313" width="241" height="9" font="font5" id="p1_t72" reading_order_no="69" segment_no="5" tag_type="text">Medical Outcomes Survey (SF-36), a comprehensive sur-<a href=""> 30) [13</a>]. Smoking was quantified in pack years, a</text>
<text top="286" left="313" width="241" height="9" font="font5" id="p1_t73" reading_order_no="70" segment_no="5" tag_type="text">vey designed to measure physical and mental health [10].</text>
<text top="298" left="313" width="241" height="9" font="font5" id="p1_t74" reading_order_no="71" segment_no="5" tag_type="text">There are 8 subscales, summarized into physical and men-</text>
<text top="310" left="313" width="241" height="9" font="font5" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="text">tal composite scores. Subjects are asked if their health lim-</text>
<text top="322" left="313" width="241" height="9" font="font5" id="p1_t76" reading_order_no="73" segment_no="5" tag_type="text">its activities during a regular day (from vigorous activities<a href="">ked [14</a>].</text>
<text top="333" left="313" width="241" height="9" font="font5" id="p1_t77" reading_order_no="74" segment_no="5" tag_type="text">to bathing or dressing), if they have problems with work</text>
<text top="345" left="313" width="241" height="9" font="font5" id="p1_t78" reading_order_no="75" segment_no="5" tag_type="text">or other activities due to physical health or emotional</text>
<text top="357" left="313" width="241" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="5" tag_type="text">problems, how they have been feeling emotionally during<a href="">ntal health [10</a>].</text>
<text top="369" left="313" width="241" height="9" font="font5" id="p1_t80" reading_order_no="77" segment_no="5" tag_type="text">the last 4 weeks, if they have pain and how they rate their</text>
<text top="380" left="313" width="241" height="9" font="font5" id="p1_t81" reading_order_no="78" segment_no="5" tag_type="text">health. The SF-36 is a widely used, reliable and validated</text>
<text top="392" left="313" width="241" height="9" font="font5" id="p1_t82" reading_order_no="79" segment_no="5" tag_type="text">instrument with population specific norms that can be</text>
<text top="404" left="313" width="241" height="9" font="font5" id="p1_t83" reading_order_no="80" segment_no="5" tag_type="text">used to evaluate the burden of different diseases and treat-</text>
<text top="416" left="313" width="241" height="9" font="font5" id="p1_t84" reading_order_no="81" segment_no="5" tag_type="text">ments. The questionnaire was used in this study to assess</text>
<text top="427" left="313" width="225" height="9" font="font5" id="p1_t85" reading_order_no="82" segment_no="5" tag_type="text">patients' baseline level of physical and mental health.</text>
<text top="451" left="313" width="241" height="9" font="font5" id="p1_t86" reading_order_no="83" segment_no="7" tag_type="text">QoL was measured with the Functional Assessment of</text>
<text top="463" left="313" width="241" height="9" font="font5" id="p1_t87" reading_order_no="84" segment_no="7" tag_type="text">Cancer Therapy (FACT-G), a 27 item core questionnaire</text>
<text top="474" left="313" width="241" height="9" font="font5" id="p1_t88" reading_order_no="85" segment_no="7" tag_type="text">evaluating physical, functional, social and emotional</text>
<text top="486" left="313" width="241" height="9" font="font5" id="p1_t89" reading_order_no="86" segment_no="7" tag_type="text">well-being within the previous 7 days [15]. While some</text>
<text top="498" left="313" width="241" height="9" font="font5" id="p1_t90" reading_order_no="87" segment_no="7" tag_type="text">questions are similar to those asked on the SF-36, most</text>
<text top="510" left="313" width="241" height="9" font="font5" id="p1_t91" reading_order_no="88" segment_no="7" tag_type="text">questions are specific to cancer and its treatment. For</text>
<text top="521" left="313" width="241" height="9" font="font5" id="p1_t92" reading_order_no="89" segment_no="7" tag_type="text">example, both instruments ask if the patient has pain, and</text>
<text top="533" left="313" width="241" height="9" font="font5" id="p1_t93" reading_order_no="90" segment_no="7" tag_type="text">if they are full of pep (SF-36) or have a lack of energy</text>
<text top="545" left="313" width="241" height="9" font="font5" id="p1_t94" reading_order_no="91" segment_no="7" tag_type="text">(FACT-G), however, the FACT-G was developed specifi-</text>
<text top="557" left="313" width="241" height="9" font="font5" id="p1_t95" reading_order_no="92" segment_no="7" tag_type="text">cally to include items that are affected by the diagnosis of<a href=""> [15]</a>. While some</text>
<text top="568" left="313" width="241" height="9" font="font5" id="p1_t96" reading_order_no="93" segment_no="7" tag_type="text">cancer and its treatment. Items are summed to give scores</text>
<text top="580" left="313" width="241" height="9" font="font5" id="p1_t97" reading_order_no="94" segment_no="7" tag_type="text">for each domain. All domains are scored so that a higher</text>
<text top="592" left="313" width="241" height="9" font="font5" id="p1_t98" reading_order_no="95" segment_no="7" tag_type="text">score indicates higher QoL [16]. The FACT-G is a reliable</text>
<text top="604" left="313" width="241" height="9" font="font5" id="p1_t99" reading_order_no="96" segment_no="7" tag_type="text">and validated instrument for measuring QoL in cancer</text>
<text top="615" left="313" width="162" height="9" font="font5" id="p1_t100" reading_order_no="97" segment_no="7" tag_type="text">patients, including the elderly [15,16].</text>
<text top="639" left="313" width="241" height="9" font="font5" id="p1_t101" reading_order_no="98" segment_no="10" tag_type="text">In addition to analyzing the four domain scores, five ques-</text>
<text top="651" left="313" width="241" height="9" font="font5" id="p1_t102" reading_order_no="99" segment_no="10" tag_type="text">tions were selected a priori for analysis to determine the</text>
<text top="662" left="313" width="241" height="9" font="font5" id="p1_t103" reading_order_no="100" segment_no="10" tag_type="text">distribution of responses (not at all to very much). Two</text>
<text top="674" left="313" width="241" height="9" font="font5" id="p1_t104" reading_order_no="101" segment_no="10" tag_type="text">questions not directly related to treatment were selected<a href="">[16]. </a>The FACT-G is a reliable</text>
<text top="686" left="313" width="241" height="9" font="font5" id="p1_t105" reading_order_no="102" segment_no="10" tag_type="text">from the physical well-being domain, and one question</text>
<text top="698" left="313" width="241" height="9" font="font5" id="p1_t106" reading_order_no="103" segment_no="10" tag_type="text">each from the social, emotional and functional well-being<a href="">rly [15</a>,<a href="">16].</a></text>
<text top="709" left="313" width="241" height="9" font="font5" id="p1_t107" reading_order_no="104" segment_no="10" tag_type="text">domains. The questions addressed level of energy, pain,</text>
<text top="721" left="313" width="241" height="9" font="font5" id="p1_t108" reading_order_no="105" segment_no="10" tag_type="text">support from family, feeling nervous and ability to enjoy</text>
</page>
</pdf2xml>
